Bolder biotech investments, not less, is key to better health outcomes for all
The goal is expanding access to drugs and the types of patients that can benefit from treatments.
Add BT as a preferred source
HEALTHCARE costs are rising globally. This is driven by ageing populations, lifestyle demographic shifts, newer treatments being offered, and a skilled manpower shortage.
Since the Covid-19 pandemic, inflationary pressures have been experienced across the healthcare industry. The WTW Global Medical Trends Survey projects more than 10 per cent increase in medical costs in 2025.
Yet, evidence of an association between healthcare costs and quality outcomes is inconsistent.
TRENDING NOW
Watch live: PM Wong, Chan Chun Sing to address political office-holders’ salary review in Parliament
Vietnam pitches its real economy, not a Singapore replica, in two-city IFC push
Lawsuit from ex-advisers adds to claims arising from Hao Mart’s lease of Taste Orchard
Canada’s fight with the US has far bigger stakes than trade
